c33

PDE9-IN-(S)-C33 ((S)-C33) 是一种有效的选择性 PDE9 抑制剂 (IC50 = 11 nM)。 PDE9-IN-(S)-C33 可用于中枢神经系统疾病和糖尿病的相关研究。

MC3343是一种DNMT抑制剂，对DNMT1和DNMT3a的IC50值分别为5.7 μM和1.7 μM，将骨肉瘤细胞阻断在G1或G2 M期来影响肿瘤增殖，并通过特定地重新表达调节这一生理过程的基因来诱导成骨分化，并且能够在联用阿霉素和顺铂 (CDDP) 时显示出协同作用。

NSC339614 potassium is a selective GluN1 GluN2C and GluN1 GluN2D receptors potentiator.

EC330 是一种白血病抑制因子抑制剂。

EC33, a selective aminopeptidase A (APA) inhibitor, blocks the pressor response of exogenous Ang II and does not cross the blood-brain barrier, making it a potential candidate for salt-dependent hypertension research [1].

Chloroquinoxaline sulfonamide (Chloroquinoxaline) 是拓扑异构酶 II alpha beta 毒物，具有抗肿瘤活性和免疫抑制特性，可抑制小鼠 B16 黑色素瘤细胞的增殖，可用于研究转移性结直肠癌。

Isoliquiritigenin (ISL) 属于黄酮类天然产物，抑制流感病毒复制 (EC50=24.7 μM)，也抑制 aldose reductase 的活性 (IC50=320 nM)。Isoliquiritigenin 具有抗肿瘤的活性。

Tanespimycin (KOS 953) 是一种 Hsp90 抑制剂，可选择性抑制 BT474 肿瘤细胞 Hsp90，IC50为 5 nM。它消耗细胞内 STK38 NDR1，并降低 STK38 激酶活性，还能下调stk38基因表达。

Hexadecanolide is an agent of bioactive chemicals.

Diglycyl-histidine is a tripeptide complexed with cupric ion designed to mimic specific Cu(II) transport site of ascorbate on albumin molecule.

NSC 33994 is a selective inhibitor of JAK2 (IC50 = 60 nM). It also shows no effect on Src and TYK2 tyrosine kinase activity at a concentration of 25 μM.

C-333H is a new PPARalpha gamma dual agonist.

RC-33 HCl is a selective and metabolically stable σ1 receptor agonist potentiating NGF-induced neurite outgrowth.

DRC 3321 is a bioactive chemical.

SC 33459 is a hypolipidemic agent.

Boc-3-(3-pyridyl)-D-Ala-OH 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T65405，CAS号为 98266-33-2。

Anaxirone is a synthetic triepoxide alkylating agent with potential antineoplastic activity. Anaxirone alkylates DNA via actual or derived epoxide groups, resulting in inhibition of DNA synthesis. This agent has been shown to exhibit a broad spectrum of antineoplastic activity against experimental tumors, including those resistant to other alkylating agents.

APC-3316 hydrochloride is a vinyl sulfone cysteine protease inhibitor and selective CCR4 antagonist.

APC-3316 tosylate is a vinyl sulfone cysteine protease inhibitor and selective CCR4 antagonist.

Migalastat (GR181413A free base) 是一种具有口服活性和竞争性的α-galactosidase A 抑制剂，对人α-Gal A 的IC50值为 0.04 μM。

Codrituzumab (GC3）是一种人源化针对 glypican-3 肝癌蛋白的抗体，可与索拉非尼联合使用来研究不可治愈的晚期肝细胞癌 (HCC） 。

Myhc-α(334–352) 是一个包括MYHC-α第 334 至第 352 个氨基酸的肌球蛋白重链 α 序列片段。此段落具有显著的免疫优势表位 (immunodominant epitope) 功能，可诱导A J小鼠产生自身免疫反应并导致心肌炎。因此，Myhc-α(334–352)广泛应用于研究心肌炎及扩张型心肌病的自身免疫机制。

IRC-083927 HCl is novel and potent microtubule inhibitor with potential anticancer activity. IRC-083927 inhibits the tubulin polymerization by a binding to the colchicine site. IRC-083927 inhibits in vitro cell growth of human cancer cell lines in the low nanomolar range. More interesting, it remains highly active against cell lines resistant to microtubule-interacting agents (taxanes, Vinca alkaloids, or epothilones). Chronic oral treatment with IRC-083927 (5 mg kg) inhibits the growth of two human tumor xenografts in nude mice (C33-A, human cervical cancer and MDA-MB-231, human hormone-independent breast cancer). Together, the antitumor effects induced by IRC-083927 on tumor models resistant to tubulin agents support further investigations to fully evaluate its potential for the treatment of advanced cancers, particularly those resistant to current clinically available drugs.